Intratumoral Injection

2

Review clinical trials related to Intratumoral Injection. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

Study of RiMO-301 and Radiotherapy With PD-1 Inhibitor for the Treatment of Head-Neck Cancer

This is a prospective, open-label, single arm, non-randomized study of RiMO-301 with hypofractionated radiation and a PD-1 Inhibitor in patients with unresectable, recurrent or metastatic head-neck cancer.

Participants needed: 16
Trial details
Phase: Phase 1, Phase 2Age: 18+Biological sex: AllType: InterventionalSponsor: Coordination Pharmaceuticals, Inc.Updated: Sep 17, 2025Locations: 1
Eligibility criteria

Diagnosis of head-neck cancer that requires palliative radiotherapy [+11]

Have signs or symptoms of end organ failure, major chronic illnesses other than... [+6]

Status: Recruiting

The Clinical Efficacy and Safety of Intratumoral Injection of Chemotherapy for Advanced Solid Tumors

This project intends to investigate the clinical efficacy of intra-tumoural injection of chemotherapeutic agents (e.g. cisplatin, oxaliplatin, etc.)via fine needle aspiration guided by CT or ultrasound in patients with advanced solid cancers to validate the safety and efficacy.

Participants needed: 200
Trial details
Age: 18-85Biological sex: AllType: InterventionalSponsor: Wuxi People's HospitalUpdated: May 28, 2024Locations: 1
Eligibility criteria

Male or female aged 18-75 years; [+5]

The patient is diagnosed with central nervous system leukemia(symptoms, signs, i... [+9]